| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.042 | 0.5 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.031 | 0.5 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.5 |